This inventor holds 2 USPTO granted patents. Top assignees: Kaken Kagaku Kabushiki Kaisha, Taito Company, Ltd.. Active years: 1976.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976
Title: The Innovations of Sumio Sakai
Introduction
Sumio Sakai is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical treatments, particularly in the area of tumor and bacterial infection therapies. With a total of two patents to his name, Sakai's work has the potential to impact healthcare positively.
Latest Patents
Sakai's latest patents include innovative treatments for tumors and bacterial infections. The first patent focuses on the treatment of malignant tumors through the administration of therapeutic compositions that comprise the chemical compound glucan. The second patent addresses the prevention and treatment of bacterial infections by activating the reticuloendothelial system with glucan that has a beta-1, 3-linkage in the main chain, along with its derivatives and partially hydrolyzed products.
Career Highlights
Throughout his career, Sumio Sakai has worked with prominent companies such as Kaken Kagaku Kabushiki Kaisha and Taito Company, Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in medical treatments.
Collaborations
Sakai has collaborated with notable individuals in his field, including Nobuhiko Komatsu and Gosaku Saito. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Sumio Sakai's contributions to medical innovation through his patents on glucan compositions demonstrate his commitment to improving health outcomes. His work in treating tumors and bacterial infections showcases the potential of scientific research to create effective therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile